CB Therapeutics
Biotechnology ResearchCalifornia, United States11-50 Employees
CB Therapeutics is a biotechnology research company based in Carlsbad, California, focusing on the discovery, research, development, and production of high-value molecular compounds and rare ingredients. Its work centers on creating phytochemicals and other molecules through diverse production platforms, including yeast, bacteria, and cell-free systems, with the aim of achieving faster, more sustainable manufacturing, higher yields, and greater purity and consistency. The company targets applications in neuroscience, particularly pursuing tryptamines and cannabinoids to advance mental health therapeutics. Positioned within the biotechnology and neuroscience research landscape, CB Therapeutics emphasizes cellular production processes and synthetic genomics to address complex mental health and social challenges. The organization operates with a relatively small team and has publicly announced the formation of a Medical Advisory Board in late 2021 as part of advancing its scientific governance and expertise.